For example, tumor cells can induce a specific subset of neutrophils (CD10+ ALPL+) that are associated with heavy CD8+ T-cell immunosuppression, which leads to resistance to anti-PD-1 therapy [176]. The gene discussed is CD8A; the disease is neoplasm.